SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 5 - Annual statement of changes in beneficial ownership of securities:
SEC Accession No. 0001250853-15-000022
Filing Date
2015-02-06
Accepted
2015-02-06 19:41:54
Documents
1
Period of Report
2014-12-31

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primary_doc.html 5  
1 PRIMARY DOCUMENT primary_doc.xml 5 3255
  Complete submission text file 0001250853-15-000022.txt   4617
Mailing Address C/O OXIGENE, INC. 230 THIRD AVENUE WALTHAM MA 02451
Business Address
Chin Richard (Reporting) CIK: 0001337252 (see all company filings)

Type: 5 | Act: 34 | File No.: 001-36225 | Film No.: 15586409

Mailing Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010
Business Address 1555 BAYSHORE HIGHWAY, SUITE 200 BURLINGAME CA 94010 650-701-7901
Kindred Biosciences, Inc. (Issuer) CIK: 0001561743 (see all company filings)

IRS No.: 461160142 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations